Top Page
AnteoTech Ltd
(Sydney:ADO)
AnteoTech Ltd (ADO) vs. iShares MSCI Australia ETF (EWA)
AnteoTech Ltd Business Overview & Revenue Model
AnteoTech Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.06M | 968.88K | 460.40K | 365.72K | 760.88K | 898.07K |
| Gross Profit | 2.06M | 968.88K | 460.40K | 365.72K | 760.88K | 898.07K |
| EBITDA | -4.19M | -7.96M | -11.57M | -12.35M | -12.07M | -7.18M |
| Net Income | -4.48M | -6.76M | -8.88M | -12.65M | -10.72M | -6.22M |
Balance Sheet | ||||||
| Total Assets | 6.45M | 6.45M | 9.38M | 5.36M | 15.26M | 23.68M |
| Cash, Cash Equivalents and Short-Term Investments | 2.34M | 2.34M | 5.03M | 2.72M | 10.10M | 21.39M |
| Total Debt | 1.96M | 1.96M | 2.31M | 1.31M | 1.03M | 1.28M |
| Total Liabilities | 3.30M | 3.30M | 4.08M | 2.99M | 2.91M | 2.56M |
| Stockholders Equity | 3.15M | 3.15M | 5.31M | 2.38M | 12.36M | 21.11M |
Cash Flow | ||||||
| Free Cash Flow | -3.72M | -6.05M | -7.58M | -8.77M | -11.77M | -4.76M |
| Operating Cash Flow | -3.54M | -5.83M | -6.52M | -8.08M | -8.65M | -4.55M |
| Investing Cash Flow | -174.87K | -174.87K | -1.06M | -690.83K | -3.12M | -213.07K |
| Financing Cash Flow | 3.32M | 3.32M | 9.89M | 1.39M | 482.29K | 22.94M |
AnteoTech Ltd Technical Analysis
AnteoTech Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
56 Neutral | AU$90.43M | -9.45 | -49.72% | ― | ― | 10.78% | |
54 Neutral | AU$53.20M | -5.38 | -71.87% | ― | 7.65% | -19.13% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$156.83M | ― | -41.51% | ― | -40.74% | -21.21% | |
46 Neutral | AU$22.04M | ― | -143.71% | ― | 306.88% | ― | |
43 Neutral | AU$60.55M | ― | -138.54% | ― | ― | 16.61% | |
42 Neutral | AU$51.82M | ― | -159.86% | ― | 110.44% | 35.90% |
AnteoTech Ltd Corporate Events
AnteoTech Ltd has announced a change in the interests of its director, Glenda McLoughlin, involving the acquisition of 7,500,000 unlisted options and the expiry of 5,000,000 unlisted options. This adjustment in the director’s securities holdings reflects ongoing strategic decisions within the company, potentially impacting its market positioning and stakeholder interests.
AnteoTech Ltd has announced the issuance of 42.5 million unquoted options, exercisable at $0.0375, with expiration dates in 2028 and 2029. This strategic move could potentially enhance the company’s financial flexibility and strengthen its market position by providing additional capital for growth and development.
AnteoTech Ltd announced the results of its 2025 Annual General Meeting, where all resolutions were passed by poll. Notably, less than 25% of votes were against the adoption of the 2025 remuneration report, eliminating the need to consider contingent resolution 6. This outcome reflects strong shareholder support and may positively impact AnteoTech’s governance and strategic initiatives, reinforcing its position in the advanced materials industry.
AnteoTech Ltd’s 2025 AGM highlighted strategic advancements and operational restructuring under new leadership. The company reported significant progress in its Life Sciences division with the launch of AnteoBind NXT™ and a renewed agreement with the Serum Institute of India, resulting in a 110% revenue increase. In Advanced Battery Technologies, AnteoTech’s Ultranode™ X formulation achieved a major milestone, enhancing its competitiveness in the lithium-ion battery market. The company also expanded its customer engagement and entered a joint development agreement to strengthen its position in the global battery supply chain.
AnteoTech Ltd has announced a significant milestone with its Ultranode™ X anode, achieving over 1,000 charge/discharge cycles at 80% capacity retention. This development positions AnteoTech as a competitive player in the EV and eVTOL markets, offering a cost-effective and scalable anode technology. The achievement is expected to accelerate customer and partnership discussions, leveraging the use of micron-sized silicon materials that are less costly and more environmentally friendly compared to traditional composites. This advancement comes at a critical time as global supply chains face challenges, particularly with recent export restrictions from China, highlighting AnteoTech’s strategic advantage in providing trade restriction-independent solutions.
AnteoTech Ltd has achieved a significant milestone by scaling up the production of its Ultranode™ 70 silicon anode for Wyon AG, a Swiss battery manufacturer. This development marks a crucial step in the commercialisation of AnteoTech’s technology, as it prepares for performance evaluations by Wyon. The successful integration of Ultranode™ 70 is expected to enhance energy capacity and battery life, potentially leading to a commercial supply agreement with Wyon, thereby strengthening AnteoTech’s position in the consumer battery market.
AnteoTech Ltd has made significant strides in its operations during the quarter ending September 30, 2025, by executing a Joint Development and Sales Agreement with Black Diamond Structures and achieving a tenfold manufacturing scale-up of its Ultranode material. The company has also expanded its market presence by appointing a South Korean distributor and participating in international conferences, which has resulted in increased customer engagement and new sales leads. In the life sciences sector, AnteoTech has strengthened its collaborations and market engagement, leading to new orders and partnerships. The company has also appointed a new CEO, implemented a CRM system, and received a substantial R&D Tax Incentive, all while maintaining a strong cash position with no debt.
AnteoTech Ltd has announced a Notice of General Meeting concerning a potential spill meeting following its 2025 Annual General Meeting. This meeting, if necessary, is scheduled for November 26, 2025, in Brisbane. The announcement is significant as it could impact the company’s governance and strategic direction, potentially affecting stakeholders’ interests.
AnteoTech Ltd has announced the date for its Annual General Meeting, which is set to take place on November 26, 2025, in Brisbane. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and operational performance. The announcement outlines key dates for shareholders, including the deadline for director nominations and the availability of meeting details, underscoring the company’s commitment to transparent communication with its investors.
AnteoTech Ltd has entered into a Joint Development and Sales Agreement with Black Diamond Structures LLC to produce and commercialize an advanced battery product for the U.S. market. This collaboration combines AnteoTech’s Anteo X™ and BDS’s MOLECULAR REBAR® to improve the performance of high silicon lithium-ion batteries. The agreement aims to leverage BDS’s customer network and production capabilities to accelerate AnteoTech’s entry into the U.S. market. The partnership is expected to deliver significant benefits to battery manufacturers by enhancing energy density, charge rates, and battery life while reducing costs.